APA (7th ed.) Citation

Andreas Muehler, Hella Kohlhof, Manfred Groeppel, & Daniel Vitt. (2019). The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study. Adis, Springer Healthcare.

Chicago Style (17th ed.) Citation

Andreas Muehler, Hella Kohlhof, Manfred Groeppel, and Daniel Vitt. The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study. Adis, Springer Healthcare, 2019.

MLA (9th ed.) Citation

Andreas Muehler, et al. The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study. Adis, Springer Healthcare, 2019.